Level of Topoisomerase IIα Expression as a Prognostic Indicator in Patients With Breast Cancer (Literature Review)

Practical oncology
doi 10.22141/oncology.1.1.2018.155376
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House Zaslavsky

Related search

TAZ Expression as a Prognostic Indicator in Colorectal Cancer

PLoS ONE
Multidisciplinary
2013English

Immunofluorometrically Determined P53 Accumulation as a Prognostic Indicator in Italian Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
1998English

E-Cadherin as a Prognostic Indicator in Primary Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2001English

Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Cancer Management and Research
Oncology
2020English

Addressing Frailty in Patients With Breast Cancer: A Review of the Literature

European Journal of Surgical Oncology
MedicineOncologySurgery
2020English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Immunohistochemical Analysis of RTKs Expression Identified HER3 as a Prognostic Indicator of Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2014English

Elafin, an Inhibitor of Elastase, Is a Prognostic Indicator in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy